Re-runs extraction for each period with period-end year from max(2023, current year − 2) through the current year, oldest first (up to three reporting years). This can take a long time.
Sector: Healthcare
RU_GEMC
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: connector/market_inputs
| Period | Issues |
|---|---|
| 2023-06-30 H1 | ✓OK |
| 2023-12-31 FY | ✓OK |
| 2023-12-31 H2 | ✓OK |
| 2024-06-30 H1 | ✗Errors 1Warn 1 |
| 2024-12-31 FY | ✗Errors 1Warn 1 |
| 2024-12-31 H2 | ✗Errors 1Warn 2 |
| 2025-06-30 H1 | ⚠Warn 2 |
| 2025-12-31 FY | ✗Errors 1Warn 1 |
| 2025-12-31 H2 | ✗Errors 2Warn 1 |
Monetary columns are in B RUB, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueB RUB | Operating profitB RUB | D&AB RUB | EBITDAB RUB | Net profitB RUB | Operating CFB RUB | Capex + M&AB RUB | AssetsB RUB | EquityB RUB | ROE (annualized) | Net debtB RUB | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | FY 2025 (12M) | OK | 14.5 y/y 6.1% | 4.6 y/y -20.3% | 1.3 y/y 47.3% | 5.9 y/y -11.5% | 6.2 y/y -3.7% | 6.2 | -21.0 | 62.1 y/y 61.0% | 36.1 y/y 29.9% | 17.9% | 12.6 | — |
| 2025-06-30 | Q2 2025 (3M) | OK | 12.6 y/y 1.9% | 4.3 y/y -0.5% | 0.8 y/y 2.1% | 5.2 y/y -0.1% | 5.3 y/y 25.7% | 6.7 | -0.3 | 42.7 y/y 20.9% | 33.4 y/y 52.2% | 34.9% | -11.6 | — |
| 2024-12-31 | FY 2024 (12M) | OK | 13.7 y/y -13.2% | 5.8 y/y -2.9% | 0.9 y/y -17.8% | 6.6 y/y -5.1% | 6.4 y/y 6.8% | 7.1 | 3.3 | 38.6 y/y 12.2% | 27.8 y/y 50.3% | 43.0% | -5.2 | — |
| 2024-06-30 | Q2 2024 (3M) | OK | 12.4 y/y 6.3% | 4.3 y/y 12.6% | 0.8 y/y -4.9% | 5.2 y/y 9.4% | 4.2 y/y -6.2% | 5.3 | 3.6 | 35.3 y/y 1.0% | 21.9 y/y 56.5% | 42.0% | 1.2 | — |
| 2023-12-31 | FY 2023 (12M) | OK | 15.8 y/y — | 6.0 y/y — | 1.0 y/y — | 7.0 y/y — | 6.0 y/y — | 6.2 | -5.0 | 34.4 y/y — | 18.5 y/y — | 64.9% | 5.8 | — |
| 2023-06-30 | Q2 2023 (3M) | OK | 11.6 y/y — | 3.9 y/y — | 0.9 y/y — | 4.7 y/y — | 4.5 y/y — | 4.4 | -0.8 | 35.0 y/y — | 14.0 y/y — | — | 10.1 | — |
Quarterly values ($ mln)
Year-over-year change
Net debt / cash ($ mln)
Value the company creates per year, as a % of market cap
Value created per year: -41.8%
| 1. EBITDA growth (latest quarter YoY, annualised) [EBITDA latest qtr − EBITDA year-ago qtr] × annualisation X (2025-12-31 vs 2024-12-31) = (5 876 − 6 655) × 1.88 | -1 463 |
| 2. Current EV/EBITDA (LTM) (Market cap + Net debt) ÷ EBITDA (LTM) = (66 366 + 12 557) ÷ 11 038 | 7.2x |
| 3. Target multiple (Current EV/EBITDA + 6.5) ÷ 2 = (7.2 + 6.5) ÷ 2 | 6.8x |
| 4. Cash flow (balance method, LTM) Net-debt reduction + dividends + buybacks − equity issuance = -17 737 + 0 + 0 − 0 | -17 737 |
| 5. Value created per year (EBITDA growth × Target multiple + Cash flow) ÷ Market cap = (-1 463 × 6.8 + -17 737) ÷ 66 366 | -41.8% |
Amounts in millions of the reporting currency. EBITDA growth is the latest quarter vs the same quarter a year ago, annualised.
Caveats:
No dividend rows found for this issuer.
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)